ICON plc (ICLRN)
BMV
Closed
Aug 24, 2026
Day's Range
1,850.2852 wk Range
1,850.28Overview - ICLRN - ICON plc
Key Statistics
Valuation
Enterprise Value
2.45T
P/E (Trailing)
‪46.51‬
PEG Ratio
‪-0.78‬
Price / Sales (TTM)
‪17.21‬
Price / Book
‪0.89‬
EV / EBITDA
‪277.66‬
Profitability
Gross Margin
‪23.22%‬
Profit Margin
‪0.32%‬
Operating Margin
‪9.41%‬
Return on Assets
‪0.96%‬
Return on Equity
‪0.28%‬
Ownership
Shares Outstanding
77.15M
Float
77.09M
Held by Insiders
‪0.44%‬
Held by Institutions
‪108.36%‬
Price stats
Beta
‪1.20‬
50-Day Avg
‪1,850.28‬
200-Day Avg
‪2,335.22‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - ICLRN - ICON plc
Peers - ICLRN - ICON plc
Peer Comparison
Compared with companies in Diagnostics & Research listed on BMV.
- ICLRNBMVICON plc142.75BMarket Cap-83.76%52-week change46.51P/E (Trailing)‪0.32%‬Profit Margin
- TMOBMVThermo Fisher Scientific Inc.3.93TMarket Cap+14.17%52-week change34.13P/E (Trailing)‪15.03%‬Profit Margin
- DHRBMVDanaher Corporation2.59TMarket Cap-5.40%52-week change38.76P/E (Trailing)‪15.94%‬Profit Margin
- IDXXBMVIdexx Laboratories Inc.747.08BMarket Cap-27.10%52-week change39.37P/E (Trailing)‪25.03%‬Profit Margin
- IQVBMVIqvia Holdings Inc.720.87BMarket Cap+20.87%52-week change128.21P/E (Trailing)‪8.09%‬Profit Margin
- DIABMVSPDR Dow Jones Industrial Average ETF Trust701.07BMarket Cap+5.74%52-week change4.39P/E (Trailing)—Profit Margin
- ABMVAgilent Technologies Inc.663.71BMarket Cap+3.28%52-week change27.85P/E (Trailing)‪19.55%‬Profit Margin
Profile Summary - ICLRN - ICON plc
About
ICON plc is a leading global contract research organization (CRO) that provides outsourced drug and device development and commercialization services to pharmaceutical, biotechnology, medical device, and government organizations. It specializes in full-service clinical trials from Phase I to IV, including complex…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
